Y-mAbs Therapeutics Inc. Common Stock is a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapies for oncology. With a strong pipeline and partnerships, the company is poised for growth in the rapidly evolving field of cancer treatment.
